Your browser doesn't support javascript.
loading
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment.
Raith, Fabio; O'Donovan, Daniel H; Lemos, Clara; Politz, Oliver; Haendler, Bernard.
Affiliation
  • Raith F; Research & Development, Pharmaceuticals, Bayer AG, Müllerstr. 178, 13353 Berlin, Germany.
  • O'Donovan DH; Research & Development, Pharmaceuticals, Bayer AG, Müllerstr. 178, 13353 Berlin, Germany.
  • Lemos C; Bayer Research and Innovation Center, Bayer US LLC, 238 Main Street, Cambridge, MA 02142, USA.
  • Politz O; Research & Development, Pharmaceuticals, Bayer AG, Müllerstr. 178, 13353 Berlin, Germany.
  • Haendler B; Research & Development, Pharmaceuticals, Bayer AG, Müllerstr. 178, 13353 Berlin, Germany.
Int J Mol Sci ; 24(3)2023 Jan 24.
Article in En | MEDLINE | ID: mdl-36768610
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Receptors, Androgen Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Int J Mol Sci Year: 2023 Document type: Article Affiliation country: Alemania Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Receptors, Androgen Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Int J Mol Sci Year: 2023 Document type: Article Affiliation country: Alemania Country of publication: Suiza